| 189 |
Chondrodystrophy |
8 |
Human disease
|
12.5 |
| 194 |
Citrullinaemia |
2 |
Target evidence
|
76.9 |
| 197 |
Cleft palate |
11 |
Human disease
|
15.0 |
| 202 |
Coat/skin colour, oculocutaneous albinism type I (OCA1), TYR-related |
33 |
Drug
|
67.4 |
| 209 |
Coat colour, dominant white |
13 |
Drug
|
63.1 |
| 214 |
Coat colour, white spotting |
7 |
Target evidence
|
57.1 |
| 219 |
Coloboma |
9 |
Human disease
|
15.0 |
| 220 |
Severe combined immunodeficiency disease, autosomal, PRKDC-related |
2 |
Drug
|
60.8 |
| 224 |
Conotruncal heart malformations |
1 |
Human disease
|
9.0 |
| 227 |
Cor triatriatum dexter |
1 |
Human disease
|
6.5 |
| 230 |
Corneal dystrophy |
3 |
Human disease
|
17.5 |
| 236 |
Craniomandibular osteopathy, generic |
1 |
Human disease
|
9.0 |
| 243 |
Cryptorchidism |
12 |
Human disease
|
25.0 |
| 247 |
Cushing syndrome, ACTH-dependent, pituitary-dependent hyperadrenocorticism |
5 |
Human disease
|
15.0 |
| 248 |
Neutropenia, cyclic |
1 |
Target evidence
|
58.3 |
| 256 |
Cystinuria, type I - A |
2 |
Target evidence
|
86.6 |
| 258 |
Dandy-Walker syndrome |
3 |
Human disease
|
15.0 |
| 262 |
Deficiency of uridine monophosphate synthase |
2 |
Drug
|
81.1 |
| 263 |
Degenerative myelopathy |
1 |
Human gene
|
29.0 |
| 269 |
Dermatitis, atopic |
4 |
Human disease
|
40.0 |
| 270 |
Dermatomyositis |
1 |
Human disease
|
31.5 |
| 275 |
Retinal detachment |
3 |
Human disease
|
35.0 |
| 277 |
Diabetes |
5 |
Human disease
|
37.5 |
| 278 |
Diabetes insipidus |
6 |
Human disease
|
40.0 |
| 279 |
Diabetes mellitus |
11 |
Human disease
|
40.0 |
| 283 |
Diabetes mellitus, type 1 |
5 |
Human disease
|
45.0 |
| 284 |
Diabetes mellitus, type 2 |
7 |
Drug
|
89.4 |
| 290 |
Diprosopus |
3 |
Human disease
|
12.5 |
| 307 |
Pituitary hormone deficiency, generic |
1 |
Human disease
|
9.0 |
| 309 |
Dwarfism, sex-linked |
1 |
Drug
|
83.1 |
| 312 |
Dysautonomia |
5 |
Human disease
|
35.0 |
| 313 |
Congenital dyserythropoietic anaemia with dyskeratosis and progressive alopecia |
1 |
Human disease
|
24.0 |
| 317 |
Ears, crop |
1 |
Target evidence
|
55.7 |
| 319 |
Ears, folded (drop vs prick) |
4 |
Drug
|
60.7 |
| 323 |
Ectodermal dysplasia |
2 |
Target evidence
|
48.6 |
| 324 |
Ectrodactyly |
5 |
Human disease
|
15.0 |
| 325 |
Ectropion |
1 |
Human disease
|
6.5 |
| 327 |
Ehlers-Danlos syndrome, generic |
7 |
Human disease
|
35.0 |
| 328 |
Dermatosparaxis Ehlers-Danlos syndrome (dEDS), ADAMTS2-related |
4 |
Target evidence
|
66.0 |
| 335 |
Encephalomyelopathy |
4 |
Human disease
|
15.0 |
| 337 |
Entropion |
8 |
Human disease
|
17.5 |
| 340 |
Epidermolysis bullosa |
2 |
Human disease
|
32.0 |
| 341 |
Epidermolysis bullosa, dystrophic |
5 |
Drug
|
85.2 |
| 342 |
Epidermolysis bullosa, junctionalis |
3 |
Human disease
|
15.0 |
| 344 |
Epilepsy |
12 |
Drug
|
67.5 |
| 348 |
Epitheliogenesis imperfecta |
5 |
Human disease
|
15.0 |
| 353 |
Exophthalmos with strabismus |
2 |
Human disease
|
12.0 |
| 354 |
Exostoses, multiple |
3 |
Human disease
|
15.0 |
| 360 |
Facial digital syndrome |
1 |
Human disease
|
9.0 |
| 361 |
Factor VII deficiency |
2 |
Drug
|
84.2 |